Target intelligence / Profile preview

DNA within DNA topoisomerase 1-DNA complexes (TOP1cc) (TOP1cc)

Target
TOP1cc
Molecular classification
Nucleic acid, Protein-DNA complex, Enzyme-substrate complex
01

Overview

DNA within DNA topoisomerase 1 (TOP1) complexes refers to the DNA substrate as it exists in a transient covalent intermediate with the TOP1 enzyme during the relaxation of DNA supercoiling. This intermediate, known as the TOP1-DNA cleavage complex (TOP1cc), is formed when TOP1 cleaves one strand of the DNA phosphodiester backbone to allow rotation and relief of torsional strain (Pommier, 2006, Nature Reviews Cancer). Under normal physiological conditions, these complexes are short-lived as the enzyme quickly religates the DNA. However, certain chemotherapeutic agents, such as camptothecins and their derivatives (e.g., irinotecan, topotecan), act as interfacial inhibitors that bind specifically to the TOP1cc, trapping the enzyme on the DNA (Pommier et al., 2013, Chemical Reviews). These stabilized complexes pose a significant threat to genomic integrity; when DNA or RNA polymerases collide with the trapped TOP1cc, the single-strand breaks are converted into permanent, lethal double-strand breaks (DSBs) (Koster et al., 2007, Nature). This mechanism triggers DNA damage response pathways and ultimately leads to programmed cell death, making the TOP1-DNA complex a critical target in the treatment of various cancers, including colorectal, lung, and ovarian malignancies.

Other names
TOP1-DNA cleavage complexTOP1ccDNA topoisomerase 1-DNA covalent complexCleavable complexTOP1-DNA covalent complex
02

Mechanism of action

Interfacial inhibition where the drug binds at the junction of the TOP1 enzyme and the cleaved DNA strand, preventing DNA religation and leading to replication-mediated double-strand breaks.

03

Biological functions

DNA replicationTranscriptionDNA repairDNA supercoiling relaxation
04

Disease associations

Cancer
05

Safety considerations

Severe diarrheaMyelosuppressionNeutropeniaGastrointestinal toxicitySecondary malignancies
06

Interacting drugs

Camptothecin

8 more in the full profile.

07

Biomarkers

TOP1 expressionSchlafen 11 (SLFN11)Tyrosyl-DNA phosphodiesterase 1 (TDP1)ERCC1

Beyond the preview

Go deeper on DNA within DNA topoisomerase 1-DNA complexes (TOP1cc) (TOP1cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA within DNA topoisomerase 1-DNA complexes (TOP1cc) (TOP1cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call